Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope

Area of Science:

• Immunology
• Virology
• Vaccine Development

Background:

• Developing broadly neutralizing antibodies against HIV-1 is a significant challenge.
• Viral envelope proteins present transient epitopes during entry, complicating vaccine design.
• The conserved 3S motif on gp41 is exposed in the prefusion state and targeted for antibody development.

Purpose of the Study:

• To design and evaluate a novel immunogen capable of eliciting potent neutralizing antibodies against HIV-1.
• To investigate the potential of structural mimicry in vaccine design for HIV-1.
• To explore the efficacy of phage-displayed mimotopes in inducing protective immune responses.

Main Methods:

• Vaccination of animals with a modified 3S peptide (W614A-3S) to generate neutralizing antibodies.
• Selection of phage-peptide mimics (mimotopes) using a specific antibody clone (F8) as bait.
• Binding assays and molecular docking to assess antibody-mimotope interactions and structural mimicry.
• Vaccination of mice with a purified phage-mimotope (Mim_F8-1) to evaluate antibody induction and neutralization capacity.

Main Results:

• Vaccination with W614A-3S peptide successfully induced neutralizing anti-HIV-1 antibodies, including clone F8.
• Phage-peptide mimics, specifically Mim_F8-1, were identified that structurally mimic the W614A-3S motif and bind to F8.
• Vaccination with Mim_F8-1 phage elicited HIV-1-neutralizing antibodies in mice that recognized the target 3S motif.

Conclusions:

• Structural mimicry can be effectively utilized in designing immunogens for HIV-1 vaccine development.
• Phage-displayed mimotopes represent a promising platform for generating broadly neutralizing antibodies against HIV-1.
• These findings offer valuable insights into rational immunogen design for eliciting protective antibodies.